The Effect of Angiotensin Receptor-Neprilysin Inhibitor With Sodium-Glucose Cotransporter 2 Inhibitor versus Angiotensin Receptor-Neprilysin Inhibitor Without Sodium-Glucose Cotransporter 2 Inhibitor on Heart Failure Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

被引：0
|
作者：
Kommu, Sharath
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Heart Failure; Angiotensin-Receptor Neprilysin Inhibitor (ARNI); Outcomes; Ejection fraction; Cardioprotective drugs;
D O I：
10.1161/circ.148.suppl_1.12247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12247
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The combination of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors in heart failure with reduced ejection fraction patients comorbid with diabetes mellitus
    Hsiao, F. C.
    Lin, C. P.
    Chang, P. C.
    Wang, C. L.
    Chu, P. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1049 - 1049
  • [2] Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis
    Huang, Yun
    Fang, Chongbo
    Zhang, YuYu
    Ma, Lili
    Zhou, Hua
    Ye, Honghua
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 123 - 131
  • [3] Comparing angiotensin receptor-neprilysin inhibitors with sodium-glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung
    Lin, Yuan
    Lin, Ming-Shyan
    Tsai, Tzu-Hsien
    Yang, Ning-, I
    Wang, Chao-Yung
    Hsieh, I-Chang
    Hung, Ming-Jui
    Chen, Tien-Hsing
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [4] Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report
    Schumacher, Christine
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (02) : 495 - 499
  • [5] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [6] Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
    Lin, Ya-Wen
    Lin, Chun-Hsiang
    Lin, Cheng-Li
    Lin, Che-Huei
    Lin, Ming-Hung
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [7] Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction
    Sert, Sena
    Karabay, Emre
    Gungor, Baris
    Yildirimturk, Ozlem
    MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 99 - 104
  • [8] Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study
    Hsiao, Fu-Chih
    Lin, Chia-Pin
    Tung, Ying-Chang
    Chang, Po-Cheng
    McMurray, John J., V
    Chu, Pao-Hsien
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 91 - 97
  • [9] Comparison between angiotensin receptor neprilysin inhibitor-first and sodium-glucose cotransporter 2 inhibitors-first strategies in patients with symptomatic heart failure and reduced ejection fraction
    Lee, W. Weichieh
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 61 - 61
  • [10] Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
    Park, Su Yeong
    Kong, Min Gyu
    Moon, Inki
    Park, Hyun Woo
    Choi, Hyung-Oh
    Seo, Hye Sun
    Cho, Yoon Haeng
    Lee, Nae-Hee
    Lee, Kwan Yong
    Jang, Ho-Jun
    Kim, Je Sang
    Choi, Ik Jun
    Suh, Jon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 692 - 703
12345